RecallDepth
Class II Terminated

Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 9777600, Israel

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 24, 2017
Posted
May 17, 2017
Recall Number
D-0705-2017
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
North Wales, PA, United States

Reason for Recall

Microbial Contamination of Non-Sterile Products

Distribution

Nationwide

Lot / Code Info

100 (NDC 0093-4359-01) and 500 count bottles (NDC 0093-4359-05)- Lot # 07C160; Exp. 03/18 100 Unit Dose Blisters/Carton (NDC 0093-4359-93) and Individual Blister Pack (NDC 0093-4359-19) - Lot # 07C160A; Exp. 03/18

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls